Company Filing History:
Years Active: 2011-2012
Title: Lee Terry Bacheler: Innovator in Viral Research and Drug Resistance
Introduction
Lee Terry Bacheler is an accomplished inventor based in Chapel Hill, NC (US). He holds two patents that focus on improving the accuracy of predicting disease resistance to drugs and determining the replication rate of viral populations. His work has significant implications for the fields of medicine and virology.
Latest Patents
Bacheler's latest patents include "Estimation of Clinical Cut-offs" and "Method and Means for Determining the Replication Rate of a Viral Population." The first patent describes methods and systems for assessing the impact of pre-existing variations in drug susceptibility on treatment response. This invention aims to establish clinically relevant cut-off values for resistance tests. The second patent provides methods for determining the replication rate of a viral population through linear regression on signal data generated by infected cells. This invention is useful for monitoring viral diseases and identifying effective drug regimens.
Career Highlights
Throughout his career, Bacheler has worked with notable companies such as Tibotec Pharmaceuticals Ltd. and Virco Bvba. His contributions to these organizations have helped advance research in drug resistance and viral infections.
Collaborations
Bacheler has collaborated with esteemed colleagues, including Laurence Tatiana Rimsky and Herwig Gaston Emiel Van Marck. These partnerships have enriched his research and innovation efforts.
Conclusion
Lee Terry Bacheler's work in the field of drug resistance and viral research showcases his commitment to advancing medical science. His patents reflect a deep understanding of complex biological systems and their implications for treatment.